FDA Drug Recalls

Recalls / Class II

Class IID-0753-2021

Product

Carvedilol Tablets, USP 25 mg, 500 Tablets bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 0853, NDC 68382-095-05

Brand name
Carvedilol
Generic name
Carvedilol
Active ingredient
Carvedilol
Route
Oral
NDCs
68382-092, 68382-093, 68382-094, 68382-095
FDA application
ANDA077614
Affected lot / code info
Z006279, exp 12/31/2022

Why it was recalled

Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle

Recalling firm

Firm
Zydus Pharmaceuticals (USA) Inc
Manufacturer
Zydus Pharmaceuticals USA Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
73 Route 31 N, N/A, Pennington, New Jersey 08534-3601

Distribution

Quantity
2880 bottles
Distribution pattern
Nationwide in the US

Timeline

Recall initiated
2021-08-13
FDA classified
2021-08-19
Posted by FDA
2021-08-25
Terminated
2023-04-03
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0753-2021. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Carvedilol · FDA Drug Recalls